Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats (Q47326132)
Jump to navigation
Jump to search
scientific article published on 9 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats |
scientific article published on 9 August 2006 |
Statements
1 reference
Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats (English)
1 reference
Tobias Engelhorn
1 reference
Arnd Doerfler
1 reference
Gerd Heusch
1 reference
9 August 2006
1 reference
1 reference
406
1 reference
1-2
1 reference
92-96
1 reference
Identifiers
1 reference
1 reference